Neurol. praxi. 2018;19(3):187-192 | DOI: 10.36290/neu.2018.002

Epileptic seizures in patients with multiple sclerosis

MUDr. Ema Kantorová, Ph.D., MUDr. Babeta Hofericová, prof. MUDr. Egon Kurča, Ph.D.
Neurologická klinika, Univerzitná nemocnica, Martin

Epileptic seizures are defined as a transient occurrence of symptoms due to abnormal disinhibited or extremely synchronisedcortical activity. When they occurr in isolation, they can be provoked by different processes influencing brain cortex. However,repeated epileptic seizures signalise irreversible microscopic or macroscopic damage of the brain cortex. Intensity of inflammatoryprocess in the brain cortex and intensity of post-inflammatory changes correlate with epileptic seizures and epilepsy in multiplesclerosis. In this article we are dealing with current information about epilepsy and multiple sclerosis.

Keywords: epileptic seizures, epilepsy, multiple sclerosis

Received: December 19, 2017; Accepted: January 7, 2018; Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kantorová E, Hofericová B, Kurča E. Epileptic seizures in patients with multiple sclerosis. Neurol. praxi. 2018;19(3):187-192. doi: 10.36290/neu.2018.002.
Download citation

References

  1. Anderson G, Rodriguez M. Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin. Eur J Neurol 2011; 18(5): 680-685. Go to original source... Go to PubMed...
  2. Beghi E, Shorvon S. Antiepileptic drugs and the immune system. Epilepsia 2011; 52(Suppl. 3): 40-44. Go to original source... Go to PubMed...
  3. B? L, Vedeler CA, Nyland HI, Trapp BD, M?rk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62(7): 723-732. Go to original source... Go to PubMed...
  4. Calabrese M, Castellaro M, Bertoldo A, De Luca A, Pizzini FB, Ricciardi GK, Pitteri M, Zimatore S, Magliozzi R, Benedetti MD, Manganotti P, Montemezzi S, Reynolds R, Gajofatto A, Monaco S. Epilepsy in multiple sclerosis: The role of temporal lobe damage. Mult Scler 2017; 23(3): 473-482. Go to original source... Go to PubMed...
  5. Calabrese M, De Stefano N, Atzori M, Bernardi V, Mattisi I, Barachino L, Rinaldi L, Morra A, McAuliffe MM, Perini P, Battistin L, Gallo P. Extensive cortical inflammation is associated with epilepsy in multiple sclerosis. J Neurol 2008; 255(4): 581-586. Go to original source... Go to PubMed...
  6. Ehling P, Bittner S, Budde Th, Wiendl H, Meuth SG. Ion channels in autoimmune neurodegeneration, FEBS Letters 2011: 585. Go to original source... Go to PubMed...
  7. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, Peltola J, Roulet Perez E, Scheffer IE, Zuberi SM. Operational classification of seizure types by the Inter-national League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 522-530. Go to original source... Go to PubMed...
  8. Gasparini S, Ferlazzo E, Ascoli M, Sueri C, Cianci V, Russo C, Pisani LR, Striano P, Elia M, Beghi E, Colica C, Aguglia U. Epilepsy Study Group of the Italian Neurological Society. Risk fac-tors for unprovoked epileptic seizures in multiple sclerosis: a systematic review and meta-analysis. Neurol Sci 2017; 38(3): 399-406. Go to original source... Go to PubMed...
  9. Geurts JJG, Bö L, Pouwels PJW, Castelijns JA, Polman CH, Barkhof F. Cortical lesions in multiple sclerosis: combined post-mortem MR imaging and histopathology. Am J Neurorad 2005; 26(3): 572-527.
  10. Kelley BJ, Rodriguez M. Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management. CNS Drugs 2009; 23(10): 805-15. Go to original source... Go to PubMed...
  11. Kinnunen E, Wikström J. Prevalence and prognosis of epilepsy in patients with multiple sclerosis. Epilepsia 1986; 27(6): 729-33. Go to original source... Go to PubMed...
  12. Krýsl D. Autoimunitní encefalitídy. Neurol praxi 2015; 16(6): 317-323.
  13. Lisá I, Lisý L. Akútne leukoencefalopatie - diferenciálna diagnostika. Neurol. praxi 2006; (3): 94-98.
  14. Marrie RA, Reider N, Cohen J, Trojano M, Sorensen PS, Cutter G, Reingold SC, Stuve O. A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multi-ple sclerosis. Mult Scler 2015; 21(3): 342-349. Go to original source... Go to PubMed...
  15. Marusič P, Vojtěch Z. Epilepsie. In: Štětkářová I, a kol. Moderní farmakoterapie v neurologii. 2015. Maxdorf. ISBN 978-80-7345-453-1, s: 37-45.
  16. Nicholas R, Magliozzi R, Campbell G, Mahad D, Reynolds R. Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosis. Mult Scler 2016; 22(1): 25-35. Go to original source... Go to PubMed...
  17. Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50(3): 389-400. Go to original source... Go to PubMed...
  18. Sokic DV, Stojsavljevic N, Drulovic J, Dujmovic I, Mesaros S, Ercegovac M, Peric V, Draguti-novic G, Levic Z. Seizures in multiple sclerosis. Epilepsia 2001; 42(1): 72-9. Go to original source... Go to PubMed...
  19. Spatt J, Chaix R, Mamoli B. Epileptic and non-epileptic seizures in multiple sclerosis. J Neurol 2001; 248(1): 2-9. Go to original source... Go to PubMed...
  20. Spatt J, Goldenberg G, Mamoli B. Simple dysphasic seizures as the sole manifestation of relapse in multiple sclerosis. Epilepsia 1994; 35(6): 1342-1345. Go to original source... Go to PubMed...
  21. Striano P, Orefice G, Brescia Morra V, Boccella P, Sarappa C, Lanzillo R,Vacca G, Striano S. Epileptic seizures in multiple sclerosis: clinical and EEG correlations. Neurol Sci 2003; 24(5): 322-328. Go to original source... Go to PubMed...
  22. Štetkářová I, Medová E, Bučilová V, Vymazal J. Progresivní multifokální leukoencefalopatie u nemocné s roztroušenou sklerózou léčenou natalizumabem. Ces Radiol 2013; 67(1): 35-38.
  23. Weinsfeld-Adams JD, Katz Sand IB, Honce JM, Lublin FD. Differential diagnosis of mendelian and mitochondrial disorders in patients with suspected multiple sclerosis. Brain 2015; 138: 517-539. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.